The Effect of MSM and CD4+ Count on the Development of Cancer AIDS (AIDS-defining Cancer) and Non-cancer AIDS in the HAART Era.
CONCLUSION: This study demonstrates the importance of considering competing risks, and time-dependent biomarker in the survival model. MSM have higher hazard for cancer AIDS. CD4+ count is associated with both survival outcomes.
PMID: 30520378 [PubMed - as supplied by publisher]
Source: Current HIV Research - Category: Infectious Diseases Authors: Mondal P, Lim HJ, Ohtn Cohort Study Team Tags: Curr HIV Res Source Type: research
More News: Cancer | Cancer & Oncology | Epidemics | Epidemiology | Highly Active Antiretroviral Therapy | HIV AIDS | Infectious Diseases | Study